Invention Grant
- Patent Title: Methods and pharmaceutical compositions for treating peripheral demyelinating diseases
-
Application No.: US15572001Application Date: 2016-05-19
-
Publication No.: US10758548B2Publication Date: 2020-09-01
- Inventor: Nicolas Tricaud , Sergio Gonzalez
- Applicant: INSERM (INSTITUT NATIONAL DE LA RECHERCHE MEDICALE) , UNIVERSITE DE MONTPELLIER
- Applicant Address: FR Paris FR Montpellier
- Assignee: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE),UNIVERSITE DE MONTPELLIER
- Current Assignee: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE),UNIVERSITE DE MONTPELLIER
- Current Assignee Address: FR Paris FR Montpellier
- Agency: W&C IP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@721027a1
- International Application: PCT/EP2016/061334 WO 20160519
- International Announcement: WO2016/184988 WO 20161124
- Main IPC: A61K31/575
- IPC: A61K31/575 ; A61P25/02 ; A61K31/713 ; G01N33/50
Abstract:
The present invention relates to methods and pharmaceutical compositions for treating peripheral demyelinating diseases. In particular the present invention relates to a method of treating a peripheral demyelinating disease in a subject in need thereof comprising administering to the subject a therapeutically effective amount of an inhibitor of VDAC1 activity or expression.
Public/Granted literature
- US20180140617A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING PERIPHERAL DEMYELINATING DISEASES Public/Granted day:2018-05-24
Information query
